Literature DB >> 12062285

Pulmonary resection for metastases from colorectal cancer: factors influencing prognosis. Twenty-year experience.

Ottavio Rena1, Caterina Casadio, Franco Viano, Riccardo Cristofori, Enrico Ruffini, Pier Luigi Filosso, Giuliano Maggi.   

Abstract

OBJECTIVE: We reviewed our experience in the surgical management of 80 patients with colorectal pulmonary metastases and investigated factors affecting survival.
MATERIAL AND METHODS: From January 1980 to December 2000, 80 patients, 43 women and 37 men with median age 63 years (range 38-79 years) underwent 98 open surgical procedure (96 muscle-sparing thoracotomy, one clamshell and one median sternotomy) for pulmonary metastases from colorectal cancer (three pneumonectomy, 17 lobectomy, seven lobectomy plus wedge resection, six segmentectomy, three segmentectomy plus wedge resection and 62 wedge resection). Pulmonary metastases were identified at a median interval of 37.5 months (range 0-167) from primary colorectal resection. Second and third resections for recurrent metastases were done in seven and in four patients, respectively.
RESULTS: Operative mortality rate was 2%. Overall, 5-year survival was 41.1%. Five-year survival was 43.6% for patients submitted to single metastasectomy and 34% for those submitted to multiple ones. Five-year survival was 55% for patients with disease-free interval (DFI) of 36 months or more, 38% for those with DFI of 0-11 months and 22.6% for those with DFI of 12-35 months (P=0.04). Five-year survival was 58.2% for patients with normal preoperative carcino-embryonic antigen (CEA) levels and 0% for those with pathologic ones (P=0.0001). Patients submitted to second-stage operation for recurrent local disease had 5-year survival rate of 50 vs. 41.1% of those submitted to single resection (P=0.326).
CONCLUSIONS: Pulmonary resection for metastases from colorectal cancer may help survival in selected patients. Single metastasis, DFI>36 months, normal preoperative CEA levels are important prognostic factors. When feasible, re-operation is a safe procedure with satisfactory long-term results.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062285     DOI: 10.1016/s1010-7940(02)00088-x

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  46 in total

1.  Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases.

Authors:  Michel Gonzalez; John Henri Robert; Nermin Halkic; Gilles Mentha; Arnaud Roth; Thomas Perneger; Hans Beat Ris; Pascal Gervaz
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

Review 2.  Pulmonary metastasis: rationale for local treatments and techniques.

Authors:  Jun Nakajima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-09-22

3.  When professional opinion is not enough.

Authors:  Tom Treasure; Martin Utley; Ian Hunt
Journal:  BMJ       Date:  2007-04-21

Review 4.  Evolving management of colorectal cancer.

Authors:  Jochem van der Voort van Zijp; Harald J Hoekstra; Marc D Basson
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

5.  Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases.

Authors:  Ya Ruth Huo; Derek Glenn; Winston Liauw; Mark Power; Jing Zhao; David L Morris
Journal:  Eur Radiol       Date:  2016-05-10       Impact factor: 5.315

6.  Clinical Value of a One-Stop-Shop Low-Dose Lung Screening Combined with (18)F-FDG PET/CT for the Detection of Metastatic Lung Nodules from Colorectal Cancer.

Authors:  Yeon-Hee Han; Seok Tae Lim; Hwan-Jeong Jeong; Myung-Hee Sohn
Journal:  Nucl Med Mol Imaging       Date:  2015-12-17

7.  Postoperative surveillance recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial.

Authors:  Vassiliki L Tsikitis; Kishore Malireddy; Erin A Green; Brent Christensen; Richard Whelan; Jace Hyder; Peter Marcello; Sergio Larach; David Lauter; Daniel J Sargent; Heidi Nelson
Journal:  J Clin Oncol       Date:  2009-06-29       Impact factor: 44.544

8.  Outcomes after hepatic and pulmonary metastasectomies compared with pulmonary metastasectomy alone in patients with colorectal cancer metastasis to liver and lungs.

Authors:  Norifumi Hattori; Yukihide Kanemitsu; Koji Komori; Yasuhiro Shimizu; Tsuyoshi Sano; Yoshiki Senda; Tetsuya Mitsudomi; Takayuki Fukui
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

9.  Prognostic factors of pulmonary metastasectomy for colorectal carcinomas.

Authors:  Fengshi Chen; Nobuharu Hanaoka; Kiyoshi Sato; Takuji Fujinaga; Makoto Sonobe; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

10.  Video-assisted thoracic surgery (VATS) for resection of metastatic adenocarcinoma as an acceptable alternative.

Authors:  Marilee Carballo; Mary S Maish; Dawn E Jaroszewski; Amy Yetasook; Karl Bauer; Robert B Cameron; E Carmack Holmes
Journal:  Surg Endosc       Date:  2008-12-31       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.